AOD-9604 Research Exclusions and Evidence Gaps AOD-9604 is a research compound with no FDA-approved indication for any patient population
In aged mice, treatment with 5-amino-1mq combined with exercise produced remarkable results
Second, when two sources differ by that much, at least one of them is not describing what it claims to describe
For athletes and body-recomp goals, the signal is promising , but evidence-based protocols require human trials to confirm efficacy, safety, and optimal integration with training/nutrition
It remains a research compound that some clinics and individuals have begun using despite the lack of regulatory approval
Site rotation importance Repeatedly injecting in the same location can cause local tissue changes including lipohypertrophy (abnormal fat accumulation) or lipoatrophy (fat loss creating depressions)